RENOVORX, INC. Net Income
RENOVORX, INC. (RNXT) reported Net Income of -$2.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-13
- RENOVORX, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$2.91M.
- RENOVORX, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$3.52M.
- RENOVORX, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$2.94M.
- RENOVORX, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$2.91M.
- RENOVORX, INC. net income (loss) attributable to parent for fiscal 2025 was -$11.17M.
- RENOVORX, INC. net income (loss) attributable to parent for fiscal 2024 was -$8.81M.
- RENOVORX, INC. net income (loss) attributable to parent for fiscal 2023 was -$10.23M.
- RENOVORX, INC. net income (loss) attributable to parent for fiscal 2022 was -$9.89M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.91M 10-Q · filed 2026-08-13 | -$6.43M 10-Q · filed 2026-08-13 | -$9.37M derived: sum of 3 quarters · filed 2026-08-13 | -$12.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$3.52M 10-Q · filed 2026-08-13 | -$6.46M derived: sum of 2 quarters · filed 2026-08-13 | -$9.37M derived: sum of 3 quarters · filed 2026-08-13 | -$12.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.85M derived: sum of 2 quarters · filed 2026-03-30 | -$8.75M derived: sum of 3 quarters · filed 2026-08-13 | -$11.17M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$2.91M 10-Q · filed 2025-11-13 | -$5.81M derived: sum of 2 quarters · filed 2026-08-13 | -$8.23M 10-Q · filed 2025-11-13 | -$11.11M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.90M 10-Q · filed 2026-08-13 | -$5.32M 10-Q · filed 2026-08-13 | -$8.19M derived: sum of 3 quarters · filed 2026-08-13 | -$10.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.42M 10-Q · filed 2026-08-13 | -$5.30M derived: sum of 2 quarters · filed 2026-08-13 | -$7.77M derived: sum of 3 quarters · filed 2026-08-13 | -$10.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2024-12-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.35M derived: sum of 2 quarters · filed 2026-03-30 | -$7.74M derived: sum of 3 quarters · filed 2026-03-30 | -$8.81M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.47M 10-Q · filed 2025-11-13 | -$4.86M derived: sum of 2 quarters · filed 2025-11-13 | -$5.94M 10-Q · filed 2025-11-13 | -$9.16M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$2.39M 10-Q · filed 2025-11-13 | -$3.46M 10-Q · filed 2025-08-14 | -$6.69M derived: sum of 3 quarters · filed 2025-11-13 | -$8.11M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | -$1.08M 10-Q · filed 2025-11-13 | -$4.30M derived: sum of 2 quarters · filed 2025-11-13 | -$5.72M derived: sum of 3 quarters · filed 2025-11-13 | -$8.05M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | -$3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$4.65M derived: sum of 2 quarters · filed 2025-04-01 | -$6.97M derived: sum of 3 quarters · filed 2025-04-01 | -$10.23M 10-K · filed 2025-04-01 |
| 2023-09-30 | -$1.42M 10-Q · filed 2024-11-13 | -$3.75M derived: sum of 2 quarters · filed 2024-11-13 | -$7.00M 10-Q · filed 2024-11-13 | -$9.16M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$2.33M 10-Q · filed 2024-11-13 | -$5.58M 10-Q · filed 2024-08-13 | -$7.74M derived: sum of 3 quarters · filed 2024-11-13 | -$9.88M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-03-31 | -$3.26M 10-Q · filed 2024-11-13 | -$5.41M derived: sum of 2 quarters · filed 2024-11-13 | -$7.55M derived: sum of 3 quarters · filed 2024-11-13 | -$10.14M derived: sum of 4 quarters · filed 2024-11-13 |
| 2022-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.29M derived: sum of 2 quarters · filed 2024-04-01 | -$6.89M derived: sum of 3 quarters · filed 2024-04-01 | -$9.89M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$2.14M 10-Q · filed 2023-11-13 | -$4.73M derived: sum of 2 quarters · filed 2023-11-13 | -$7.73M 10-Q · filed 2023-11-13 | -$10.09M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$2.59M 10-Q · filed 2023-11-13 | -$5.60M 10-Q · filed 2023-08-16 | -$7.95M derived: sum of 3 quarters · filed 2023-11-13 | -$9.46M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-03-31 | -$3.00M 10-Q · filed 2023-11-13 | -$5.36M derived: sum of 2 quarters · filed 2023-11-13 | -$6.87M derived: sum of 3 quarters · filed 2023-11-13 | -$8.18M derived: sum of 4 quarters · filed 2023-11-13 |
| 2021-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.87M derived: sum of 2 quarters · filed 2023-03-31 | -$5.18M derived: sum of 3 quarters · filed 2023-03-31 | -$6.32M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$1.51M 10-Q · filed 2022-11-14 | -$2.82M derived: sum of 2 quarters · filed 2022-11-14 | -$3.97M 10-Q · filed 2022-11-14 | -$4.85M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.31M 10-Q · filed 2022-11-14 | -$2.46M 10-Q · filed 2022-08-12 | -$3.34M derived: sum of 3 quarters · filed 2022-11-14 | -$4.43M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-03-31 | -$1.15M 10-Q · filed 2022-11-14 | -$2.03M derived: sum of 2 quarters · filed 2022-11-14 | -$3.12M derived: sum of 3 quarters · filed 2022-11-14 | -$3.90M derived: sum of 4 quarters · filed 2022-11-14 |
| 2020-12-31 | -$878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$1.97M derived: sum of 2 quarters · filed 2022-03-30 | -$2.75M derived: sum of 3 quarters · filed 2022-03-30 | -$3.80M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$1.10M 10-Q · filed 2021-11-15 | -$1.87M derived: sum of 2 quarters · filed 2021-11-15 | -$2.92M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$773.00K 10-Q · filed 2021-11-15 | -$1.82M derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | -$1.05M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |